Get the Stockscreener App
34.20
0.32%
0.11
Pre-market:
34.39
0.19
+0.56%
Azenta Inc stock is traded at $34.20, with a volume of 847.05K.
It is up +0.32% in the last 24 hours and up +4.01% over the past month.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
See More
Previous Close:
$34.09
Open:
$33.69
24h Volume:
847.05K
Relative Volume:
1.18
Market Cap:
$1.50B
Revenue:
$596.57M
Net Income/Loss:
$-109.88M
P/E Ratio:
-8.8279
EPS:
-3.8741
Net Cash Flow:
$28.72M
1W Performance:
+1.69%
1M Performance:
+4.01%
6M Performance:
+60.49%
1Y Performance:
+14.73%
1-Day Range:
$33.51
$34.82
1-Week Range:
$33.03
$34.88
52-Week Range:
$15.93
$41.73
Azenta Inc Stock (AZTA) Company Profile
Name
Azenta Inc
Sector
Industry
Phone
(978) 262-2400
Address
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
34.20 | 1.50B | 596.57M | -109.88M | 28.72M | -3.8741 |
ISRG
Intuitive Surgical Inc
|
399.52 | 141.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
179.23 | 48.82B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
221.89 | 32.01B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
64.56 | 31.21B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.66 | 30.41B | 29.14B | 1.07B | 1.05B | 1.1956 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-25 | Reiterated | Needham | Buy |
| Oct-30-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-06-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-22-25 | Resumed | Stephens | Equal-Weight |
| Dec-18-24 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-04-24 | Initiated | Jefferies | Hold |
| Feb-01-24 | Reiterated | B. Riley Securities | Buy |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| May-10-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-09-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-22 | Resumed | B. Riley Securities | Buy |
| Mar-21-22 | Initiated | Evercore ISI | Outperform |
View All
Azenta Inc Stock (AZTA) Latest News
Azenta faces securities fraud probe after CEO r... - Pluang
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc.AZTA - PR Newswire
Azenta, Inc. (AZTA) Stock Forecasts - finance.yahoo.com
Azenta, Inc. (AZTA) Options Chain - ca.finance.yahoo.com
Tax withholding reduces Azenta (NASDAQ: AZTA) CEO stake - Stock Titan
Azenta, Inc. (AZTA) Investor Outlook: Analyzing Growth Potential Amidst A 4.44% Upside - DirectorsTalk Interviews
Azenta formalizes interim CEO pay and retention grants - The Globe and Mail
Azenta sets compensation terms for interim CEO and grants executive retention awards - Investing.com
Form 8K Azenta Inc For: 17 September By Investing.com - Investing.com UK
Azenta (NASDAQ: AZTA) Grants 15,272 Shares to Multiomics President Martin William E. III - Kalkine Media
Azenta (NASDAQ: AZTA) Grants Interim CEO Madaus Martin D 36,653 Shares at No Cost - Kalkine Media
Azenta (AZTA) interim CEO gets new year-long stock grant - Stock Titan
Azenta (AZTA) grants 4,586 stock units to accounting VP - Stock Titan
Azenta, Inc. (AZTA) awards 15,272 stock units to its top lawyer - Stock Titan
Azenta Inc. (AZTA) Steadies Near $30.17 as Traders Watch $31.68 ResistanceDouble Top - dars.gov.et
Azenta, Inc. (AZTA) accounting chief reports owning no stock - Stock Titan
Azenta (NASDAQ: AZTA) Secures Early $35M Vendor Loan Repayment, Finalizing $63M Cash Purchase - Kalkine Media
Azenta Completes B Medical Divestiture With Loan Repayment - theglobeandmail.com
Azenta Secures Full $35M Vendor Loan Repayment from B Medical Buyer Ahead of Schedule - Kalkine Media
Azenta completes B Medical sale as vendor loan repaid (AZTA) - Seeking Alpha
Azenta receives full $35M vendor loan repayment, completing $63M sale of B Medical Systems. - Pluang
Azenta Receives Full $35 Million Vendor Loan Repayment From B Medical Sale - citybiz
Azenta receives full $35.37M repayment, completes $63M sale of B Medical Systems - TradingView
Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems - PR Newswire
Azenta CEO resignation sparks 12% stock drop am... - Pluang
How Investors Are Reacting To Azenta (AZTA) CEO Resignation And Interim Leadership Change - simplywall.st
Azenta CEO Resigns as Interim Leader Reassures Outlook - The Globe and Mail
Why Azenta (AZTA) Stock Is Down Today - Barchart.com
Azenta CEO John Marotta Steps Down; Dr. Martin Madaus Named Interim CEO - Kalkine Media
Azenta appoints interim CEO as John Marotta resigns By Investing.com - Investing.com Nigeria
Azenta Names Martin Madaus Interim CEO, Reaffirms Revenue Guidance - citybiz
AZENTA ANNOUNCES LEADERSHIP TRANSITION - marketscreener.com
Azenta appoints interim CEO as John Marotta resigns - Investing.com India
ETFs Investing in Azenta, Inc. Stocks - TradingView
Azenta (AZTA) Results Check: EPS Beats Its Estimate for the Current Session; Price Move: Shares Move Lower 1.79% in the Available RecordNew Analyst Coverage - vinanet.vn
Azenta, Inc. Earnings Call Balances Growth And Strain - theglobeandmail.com
Azenta, Inc.: Financial Data Forecasts Estimates and Expectations | BA3 | US1143401024 - marketscreener.com
Azenta: Needs To Overcome A Few Hurdles If The Rally Is To Continue (NASDAQ:AZTA) - Seeking Alpha
AZTA Q2 2026 Earnings: EPS Surpasses Estimates by 37.8% on Operational StrengthReturn On Equity - vinanet.vn
Azenta Inc. (AZTA) Edges Higher to $33.53 as Life Sciences Tools Sector StabilizesExhaustion Gap - vinanet.vn
Azenta Inc. (AZTA) Edges Higher by 0.42% as Shares Trade Between Key Support and ResistanceSector Leader Stocks - dars.gov.et
The 5 Most Interesting Analyst Questions From Azenta’s Q2 Earnings Call - Yahoo! Finance Canada
Azenta (AZTA) Is Up 11.5% After Returning To Profit And Raising Revenue OutlookHas The Bull Case Changed? - webull.com
Azenta (AZTA) SVP Pirogova has 1,085 shares withheld for tax obligations - Stock Titan
Azenta, Inc. Announces Appointment of Erik J. Bello as Chief Accounting Officer, Effective August 31, 2026 - marketscreener.com
Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth in the Healthcare Sector with a 4.41% Potential Upside - DirectorsTalk Interviews
Azenta (AZTA) Holds Steady at $33.39 as Shares Trade Mid-Range Between Support and ResistanceChart Pattern Alerts - dars.gov.et
Weekly Recap: Azenta, Inc. Q3 revenue gain and analyst target raises - TradingView
Azenta Inc (AZTA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues - The National Law Review
Azenta Inc (AZTA) Stock News Today - TradingKey
Azenta Inc Stock (AZTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
3.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):